Tilray Inc. (NASDAQ: TLRY) on Wednesday announced the expansion of its global senior leadership team. The company appointed Andrew Pucher, a former managing director at Goldman Sachs Group Inc (NYSE: GS), as its new Chief Corporate Development Officer.
In his new role, Pucher will be responsible for Tilray's corporate development and will also manage the team responsible for M&A and corporate investments.
Pucher served as Head of Canadian Diversified Investment Banking at Goldman, where he also covered the country's cannabis industry. Prior to that, he was a member of Goldman's Global Healthcare Investment Banking Group, where he advised on over $200 billion in announced M&A and financing transactions, mostly in the biopharmaceutical industry.
The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Danny Moses, Alan Brochstein and many others.
Why It's Important
The appointment follows a string of hires from other industries:
The appointment comes after Tilray signed a number of deals and partnerships expanding its reach and international presence.
The company and its subsidiaries formed a partnership with Novartis AG (NYSE: NVS)'s Sandoz division to distribute medical products, created a 50/50 joint venture with Anheuser Busch Inbev NV (NYSE: BUD)'s Labatt to develop THC and CBD-infused beverages, signed an agreement to produce CBD products for Authentic Brands Group. Most recently, Tilray announced the acquisition of Manitoba Harvest, the largest manufacturer of hemp food products.
Related Links:
Former Twitter VP Joins NorCal Cannabis As Chief Marketing Officer
Morgan Stanley Executive Director Resigns To Take CFO Job In The Cannabis Industry
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.